Biotech Investors & VC Firms in Netherlands
42 firms in this list, with a median first check of $810K. Generated from verified public data and updated continuously.
Aescap Life Sciences
AmsterdamSeed–Series A
6 people
Delft Enterprises B.V.
DelftSeed–Series A
6 people
RTW Investments L.P.
New YorkSeed–Series A
6 people
Vento
TorinoPre-Seed–Seed$162K – $1.1M
3 people
BioGeneration Ventures
NaardenSeed–Late Stage
5 people
Newton Biocapital
BrusselsSeed–Series A
5 people
Vesalius Biocapital III Partners SàRL
StrassenSeries C–Late Stage$10.8M
5 people
AbbVie
CambridgeSeed–Late Stage$300K – $3M
1 person
Curie Capital
AmsterdamSeed–Series A
4 people
Novalis Biotech
GhentSeed–Series A
4 people
Aglaia Oncology Funds
BilthovenSeed–Series A
3 people
Cancer Focus
ShreveportSeries A
3 people
MedCap AB
StockholmSeed–Series A
3 people
Supermoon Capital
BelvederePre-Seed–Series A
2 people
Levante Capital
BlaricumSeed–Series A
2 people
Metaplanet
TallinnSeed–Series A
2 people
Positron Ventures
AmsterdamSeed–Series A
2 people
Waterman Ventures
UtrechtSeed–Late Stage
2 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.